AstraZeneca

+$0.88 (+1.48%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory.

CEO
Pascal Soriot
Employees
76,100
Headquarters
Cambridge, Cambridgeshire
Founded
1992

AZN Key Statistics

Market Cap
187.63B
Price-Earnings Ratio
41.26
Dividend Yield
2.31
Average Volume
4.13M
High Today
$60.49
Low Today
$59.51
Open Price
$59.56
Volume
3.37M
52 Week High
$61.34
52 Week Low
$46.48

AZN News

Benzinga18h

AstraZeneca, Unilever Tumble As FTSE 100 Struggles With Rising Energy Prices

Shares of COVID-19 vaccine maker AstraZeneca PLC (NASDAQ: AZN) along with other multinational British companies such as Unilever PLC (NYSE: UL), Diageo PLC (NYS
ReutersOct 18

Valneva says its COVID-19 vaccine shows similar protection to AstraZeneca's, fewer side effects

The logo of Valneva SE is pictured at the company's headquarters in Saint-Herblain, near Nantes, France, September 13, 2021. REUTERS/Stephane Mahe Summary Shar
MarketWatchOct 18

Pfizer and AstraZeneca vaccines were as effective as prior infection, U.K. study finds

Two doses of either the vaccine made by Pfizer PFE, -0.43% and BioNTech [s:bntx] or Oxford-AstraZeneca AZN, +0.92% vaccines provided a similar level of protecti

AZN Earnings

$0.00
$0.27
$0.55
$0.82
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.43 per share
Actual
$0.45 per share

More AZN News

MarketWatchOct 18

Valneva shares spike after saying vaccine candidate outperformed AstraZeneca's

Valneva’s wild stock-price rise continued on Monday after the French biotech said its coronavirus vaccine candidate outperformed AstraZeneca’s in a trial. Valn
MarketWatchOct 18

AstraZeneca Recommends Shareholders Reject TRC Capital Mini-Tender Bid

By Joe Hoppe AstraZeneca PLC said Monday that it has recommended shareholders reject a mini-tender offer from TRC Capital Investment Corporation for up to two
ReutersOct 15

AstraZeneca wins trial over Zydus' proposed generic of diabetes drug

REUTERS/Rachel Wisniewski/File Photo Summary Summary Law firms Zydus loses bid to invalidate AstraZeneca patent Zydus admitted infringement if patent valid
MarketWatchOct 15

AstraZeneca Says Combination of Tremelimumab and Imfinzi Antibodies Boosted Liver Cancer Survival

By Jaime Llinares Taboada AstraZeneca PLC said Friday that trials to study the combination of the tremelimumab monoclonal antibody and Imfinzi demonstrated ove
ReutersOct 14

Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine

FILE PHOTO: Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" are seen in this illustration photo (Reuters) - Australian biotech CSL said on Thursday
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure